Form D · Biotechnology
RAVGEN, INC.
Columbia, MD · CIK 0001140834
Offering snapshot reported Oct 27, 2021 · SEC filing
- Reported sold
- $2.48M Offering amount: $3.5M
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 20, 2021 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$2,450,000 → $2,481,652
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 27, 2021 | Amendment | $2,481,652 | $31,652vs Aug 9, 2021 | 11 | SEC filing |
| Aug 9, 2021 | Amendment | $2,450,000 | No comparison | Not reported | SEC filing |
| Jul 27, 2021 | Amendment | $2,150,000 | $250,000vs Jul 2, 2021 | 6 | SEC filing |
| Jul 2, 2021 | Amendment | $1,900,000 | No comparison | Not reported | SEC filing |
| Jun 3, 2021 | Initial | $800,000 | No comparison | Not reported | SEC filing |
| May 14, 2012 | Amendment | $1,091,663 | $207,263vs May 13, 2011 | 15 | SEC filing |
| May 13, 2011 | Initial | $884,400 | No comparison | 11 | SEC filing |
| Nov 14, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-401584
Source: Form D, filed Oct 27, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Philip Bayliss | Director |
| Ravinder Dhallan | Director, Executive, Promoter |
| Narender Dhallan | Director |
| Kamlesh Dhallan | Director |
| Kamlesh Miller | Director |
| Edward Mottern | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
9241 Rumsey Road
Columbia, MD, 21045
Columbia, MD, 21045